Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT00820755 · COMPLETED
Trial details
- NCT number
- NCT00820755
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2011-12-01
- Enrollment
- 583
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.